HomeTPST • NASDAQ
add
Tempest Therapeutics Inc
Previous close
$1.38
Day range
$1.34 - $1.40
Year range
$0.17 - $9.77
Market cap
34.28M USD
Avg Volume
4.47M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 9.58M | 28.27% |
Net income | -9.57M | -26.24% |
Net profit margin | — | — |
Earnings per share | -0.42 | 22.22% |
EBITDA | -9.43M | -27.62% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 31.12M | 76.80% |
Total assets | 42.17M | 37.17% |
Total liabilities | 25.23M | -1.94% |
Total equity | 16.94M | — |
Shares outstanding | 25.21M | — |
Price to book | 2.00 | — |
Return on assets | -55.36% | — |
Return on capital | -61.27% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -9.57M | -26.24% |
Cash from operations | -5.51M | 13.80% |
Cash from investing | -249.00K | -112.82% |
Cash from financing | 4.56M | 283.59% |
Net change in cash | -1.20M | 77.41% |
Free cash flow | -2.65M | 35.76% |
About
Founded
2011
Headquarters
Website
Employees
17